SE9202000D0 - A new therapeutically active compound - Google Patents

A new therapeutically active compound

Info

Publication number
SE9202000D0
SE9202000D0 SE9202000A SE9202000A SE9202000D0 SE 9202000 D0 SE9202000 D0 SE 9202000D0 SE 9202000 A SE9202000 A SE 9202000A SE 9202000 A SE9202000 A SE 9202000A SE 9202000 D0 SE9202000 D0 SE 9202000D0
Authority
SE
Sweden
Prior art keywords
active compound
therapeutically active
new therapeutically
new
compound
Prior art date
Application number
SE9202000A
Other languages
English (en)
Inventor
E M Hammarberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9202000A priority Critical patent/SE9202000D0/sv
Publication of SE9202000D0 publication Critical patent/SE9202000D0/sv
Priority to HR920935A priority patent/HRP920935A2/hr
Priority to NZ270595A priority patent/NZ270595A/en
Priority to MYPI92001795A priority patent/MY131174A/en
Priority to NZ244618A priority patent/NZ244618A/en
Priority to MX9205744A priority patent/MX9205744A/es
Priority to IS3929A priority patent/IS1644B/is
Priority to MA22959A priority patent/MA22674A1/fr
Priority to EP92921525A priority patent/EP0607274B1/en
Priority to APAP/P/1992/000434A priority patent/AP338A/en
Priority to HU9400993A priority patent/HUT68834A/hu
Priority to AT92921525T priority patent/ATE139774T1/de
Priority to DK92921525.9T priority patent/DK0607274T3/da
Priority to SK361-94A priority patent/SK36194A3/sk
Priority to YU90492A priority patent/YU90492A/sh
Priority to CA002118708A priority patent/CA2118708A1/en
Priority to EP92850237A priority patent/EP0538222A1/en
Priority to TNTNSN92088A priority patent/TNSN92088A1/fr
Priority to SI19929200249A priority patent/SI9200249A/sl
Priority to IL103373A priority patent/IL103373A0/xx
Priority to EP95118114A priority patent/EP0703229A3/en
Priority to JP5506849A priority patent/JPH07500320A/ja
Priority to CZ94510A priority patent/CZ51094A3/cs
Priority to PL92303101A priority patent/PL171013B1/pl
Priority to CN92112826A priority patent/CN1072411A/zh
Priority to AU27684/92A priority patent/AU667687B2/en
Priority to DE69211857T priority patent/DE69211857T2/de
Priority to PCT/SE1992/000708 priority patent/WO1993007135A1/en
Priority to ES92921525T priority patent/ES2089571T3/es
Priority to IS4310A priority patent/IS4310A/is
Priority to US08/144,671 priority patent/US5420151A/en
Priority to BG98684A priority patent/BG98684A/xx
Priority to NO941256A priority patent/NO941256L/no
Priority to FI941616A priority patent/FI941616A0/sv
Priority to US08/304,108 priority patent/US5500425A/en
Priority to US08/362,544 priority patent/US5616610A/en
Priority to EE9400368A priority patent/EE02981B1/xx
Priority to US08/451,983 priority patent/US5650524A/en
Priority to US08/453,494 priority patent/US5646309A/en
Priority to US08/452,982 priority patent/US5641807A/en
Priority to US08/453,225 priority patent/US5639772A/en
Priority to US08/455,113 priority patent/US5656657A/en
Priority to US08/453,630 priority patent/US5639784A/en
Priority to US08/453,648 priority patent/US5656658A/en
Priority to CN96103466A priority patent/CN1146992A/zh
Priority to GR960401967T priority patent/GR3020608T3/el
Priority to HK55997A priority patent/HK55997A/en
Priority to CY199297A priority patent/CY1992A/xx

Links

SE9202000A 1989-12-22 1992-06-29 A new therapeutically active compound SE9202000D0 (sv)

Priority Applications (48)

Application Number Priority Date Filing Date Title
SE9202000A SE9202000D0 (sv) 1992-06-29 1992-06-29 A new therapeutically active compound
HR920935A HRP920935A2 (en) 1991-10-08 1992-10-02 New therapeutically active compound
NZ270595A NZ270595A (en) 1991-10-08 1992-10-05 Separation of (r)-3-amino-5-methoxychroman from a racemic mixture
MYPI92001795A MY131174A (en) 1991-10-08 1992-10-05 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)carbamoylchroman
NZ244618A NZ244618A (en) 1991-10-08 1992-10-05 Carbamoyl chroman derivative, preparation and pharmaceutical compositions thereof
MX9205744A MX9205744A (es) 1991-10-08 1992-10-07 3-(n-isopropil-n-n-propilamino)-5-(n-isopropil)carbamoilcromano, proceso para su preparacion y composicion farmaceutica que lo contiene.
IS3929A IS1644B (is) 1991-10-08 1992-10-07 Hliðstæð aðferð við framleiðslu 3-(N-ísóprópýl-N-n-própýlamínó) -5-(N-ísóprópýl)-karbamoylkróman
MA22959A MA22674A1 (fr) 1991-10-08 1992-10-07 Un nouveau compose actif
EP92921525A EP0607274B1 (en) 1991-10-08 1992-10-08 3-(N-ISOPROPYL-N-n-PROPYLAMINO)-5-(N-ISOPROPYL)CARBAMOYLCHROMAN
APAP/P/1992/000434A AP338A (en) 1991-10-08 1992-10-08 A carbamoylchroman compound as selective 5-hydroxytryptamine.
HU9400993A HUT68834A (en) 1991-10-08 1992-10-08 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)carbamoylchroman
AT92921525T ATE139774T1 (de) 1991-10-08 1992-10-08 3-(n-isopropyl-n-u-propylamino)-5-(n- isopropyl)carbamoylchroman
DK92921525.9T DK0607274T3 (da) 1991-10-08 1992-10-08 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl)carbamoylchroman
SK361-94A SK36194A3 (en) 1991-10-08 1992-10-08 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)- -carbamoylchroman
YU90492A YU90492A (sh) 1991-10-08 1992-10-08 Novo terapeutski aktivno jedinjenje
CA002118708A CA2118708A1 (en) 1991-10-08 1992-10-08 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl) carbamoylchroman
EP92850237A EP0538222A1 (en) 1991-10-08 1992-10-08 3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl)carbamoylchroman as a selective 5-hydroxytryptamine receptor stimulant
TNTNSN92088A TNSN92088A1 (fr) 1991-10-08 1992-10-08 Un nouveau compose therapeutique actif
SI19929200249A SI9200249A (en) 1991-10-08 1992-10-08 New therapeutically active compound
IL103373A IL103373A0 (en) 1991-10-08 1992-10-08 Therapeutically active compound
EP95118114A EP0703229A3 (en) 1991-10-08 1992-10-08 Process for the preparation of 3-amino-5-methoxychroman
JP5506849A JPH07500320A (ja) 1991-10-08 1992-10-08 新規な治療的に活性な化合物
CZ94510A CZ51094A3 (en) 1991-10-08 1992-10-08 3-(n-isopropyl-n-propylamino)-5-(n-isopropyl)carbamoylchroman
PL92303101A PL171013B1 (pl) 1991-10-08 1992-10-08 Sposób wytwarzania nowego 3-(N-izopropylo-N-n-propyloamino)-5-(N-izopropylo)karbamoilochromanu PL PL PL PL PL
CN92112826A CN1072411A (zh) 1991-10-08 1992-10-08 用于治疗的新的活性化合物
AU27684/92A AU667687B2 (en) 1991-10-08 1992-10-08 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl) carbamoylchroman
DE69211857T DE69211857T2 (de) 1991-10-08 1992-10-08 3-(N-ISOPROPYL-N-u-PROPYLAMINO)-5-(N-ISOPROPYL)CARBAMOYLCHROMAN
PCT/SE1992/000708 WO1993007135A1 (en) 1991-10-08 1992-10-08 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)carbamoylchroman
ES92921525T ES2089571T3 (es) 1991-10-08 1992-10-08 3-(n-isopropil-n-n-propilamino)-5-(n-isopropil)carbamoilcromano.
IS4310A IS4310A (is) 1991-10-08 1992-12-08 Nýtt læknisfræðilega virkt efnasamband
US08/144,671 US5420151A (en) 1989-12-22 1993-10-28 Chroman derivatives
BG98684A BG98684A (en) 1991-10-08 1994-03-29 3-(n-isopropyl-n-h-propylamino)-5-(n-isopropyl) carbonoylchroman
NO941256A NO941256L (no) 1991-10-08 1994-04-07 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl)karbamoylkroman
FI941616A FI941616A0 (sv) 1991-10-08 1994-04-08 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl)-karbamoylkroman
US08/304,108 US5500425A (en) 1989-12-22 1994-09-09 Chroman derivatives and a method of treating 5-HT mediated disorders
US08/362,544 US5616610A (en) 1989-12-22 1994-10-26 (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
EE9400368A EE02981B1 (et) 1991-10-08 1994-11-23 3-(N-isopropüül-N-n-propüülamino)-5-(N-isopropüül)karbamoüülkromaan
US08/451,983 US5650524A (en) 1989-12-22 1995-05-26 Process for preparing (R)-3-amino-5-methoxychroman
US08/453,494 US5646309A (en) 1989-12-22 1995-05-30 Intermediates in the synthesis of chroman derivatives
US08/452,982 US5641807A (en) 1989-12-22 1995-05-30 Method for the treatment of depression
US08/453,225 US5639772A (en) 1989-12-22 1995-05-30 Chroman derivatives
US08/455,113 US5656657A (en) 1989-12-22 1995-05-30 Chroman derivatives
US08/453,630 US5639784A (en) 1989-12-22 1995-05-30 Method for the treatment of migraine
US08/453,648 US5656658A (en) 1989-12-22 1995-05-30 Method for the treatment of anxiety
CN96103466A CN1146992A (zh) 1991-10-08 1996-02-28 中间体(r)-3-氨基-5-甲氧基苯并二氢吡喃的制备方法
GR960401967T GR3020608T3 (en) 1991-10-08 1996-07-23 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)carbamoylchroman.
HK55997A HK55997A (en) 1991-10-08 1997-05-01 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl) carbamoylchroman
CY199297A CY1992A (en) 1991-10-08 1997-09-05 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl)carbamoylchroman

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202000A SE9202000D0 (sv) 1992-06-29 1992-06-29 A new therapeutically active compound

Publications (1)

Publication Number Publication Date
SE9202000D0 true SE9202000D0 (sv) 1992-06-29

Family

ID=20386641

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202000A SE9202000D0 (sv) 1989-12-22 1992-06-29 A new therapeutically active compound

Country Status (1)

Country Link
SE (1) SE9202000D0 (sv)

Similar Documents

Publication Publication Date Title
FI955941A7 (sv) Farmaceutiskt aktiva CNS-föreningar
DK106192A (da) Hudpladeprodukt
NO179941C (no) Farmasöytisk forbindelse
DK0535034T3 (da) Farmaceutisk aktive benzoquinazolinforbindelser
ID17274A (id) Senyawa yang aktif secara farmakologi
NO943112D0 (no) Inkontinensbeskyttelse
AP9200434A0 (en) A new therapeutically active compound
SE9202000D0 (sv) A new therapeutically active compound
FI955896A7 (sv) Nya aktiva föreningar
GB9203265D0 (en) Pharmaceutically active compound
ITMI921865A1 (it) Glicerofosfoderivati farmacologicamente attivi
FI942898L (sv) Terapeutiskt aktiva peptidföreningar
SE9102905D0 (sv) A new therapeutically active compound and a process for its preparation
SE9203897D0 (sv) New active compounds iii
SE9202553D0 (sv) New active compounds ii
SE9201338D0 (sv) New active compounds
SE8902170D0 (sv) Therapeutically active compounds
GB9218797D0 (en) Pharmacologically active compounds
BR7200437U (pt) Disposicao proporcionada a arandeia
ITFE920013V0 (it) Endolancet a
SE9303970D0 (sv) New active compounds
NO932967D0 (no) Di- henholdsvis triazindioner
BR7201598U (pt) Disposicao proporcionada a micromodems
ITRM920005V0 (it) Mutadina a perdere
SE9301141D0 (sv) New active compounds iv